Abstract. Hypertension and hyperlipidemia are two main causes of cardiovascular diseases with rapidly increasing pervasiveness worldwide. Complimentary alternative medicines provide an effective choice to these highly prevalent global health issues. Nigella sativa has diverse range of traditional and pharmacological potential with established safety profile. This study was carried out in 163 mildmoderate hypertensive and hyperlipidemic patients. Patients were selected randomly of both genders. The patient's age ranges between 20-65 years. This clinical study was conducted to evaluate the clinical effect of Nigella sativa virgin oil in hypertension and hyperlipidemic patients of the selected region and also assess its antioxidative potential. The results conferred that N. sativa has significant (< 0.05) effect on controlling hypertension and hyperlipidemia as compared to standards used. Moreover, N. sativa conferred excellent antioxidant potential as compared to other commercially available edible oils.
Introduction
Hypertension is the major cause of cardiovascular diseases (CVD) which is significantly increasing day by day and according to an estimate by the end of 2025 it will go up to 1.4 billion of the world's adult population (Kearney et al., 2005) . Hypertension is defined as a systolic blood pressure greater than 140 mmHg and/or diastolic 90 mmHg or greater, and any record of serum lipid abnormality is defined as hyperlipidaemia. There are number of known cardiovascular disease, renal disease, liver disease, obesity, high cholesterol and stressful conditions; an unknown reasons of high blood pressure (essential hypertension). Hypertension is a silent killer disease as it may go undiagnosed for years and when detected had developed chronic heart disease, cardiovascular disease, diabetes mellitus, renal disease, etc. However, if properly diagnose and treat would reduce the morbidity and mortality (Schuman and Emerson, 1998) . Hypertension in long terms impairs the renal function and resulted to failure in majority of the cases (Klag et al., 1996) and these all causes cardiovascular complication (Rostand et al., 1991) . Clinical studies demonstrated that a reduction in hypertension can control 42% risk of stroke and 14% coronary heart disease (Hobbs, 2004) . In the struggle of modernization and exposure to globalization the population of low income countries greatly affected their lives to pursue their high living standards. Although some get well succeed status but many deprived in hands of cultural and social adjustments that may cause increase in hypertension. Hypertension has long been thought of Western world disease but now it is equally the part of poor countries. In addition to organic causes lifestyle play major role in this regard. The lifestyle of many people has become more westernized. Several studies hypothesized its contribution to hypertension in urban populations when compared to rural populations (Ma et al., 2012) . Within the non-communicable diseases hypertension plays leading role posing threats of disabilities (WHO, 2013) and this is because of unawareness to these conditions by a high number of hypertensive individuals (Kayima et al., 2013) . In a study of prevalence of hypertension, in low and middle income countries the blood pressure found in more than half of population higher than in US (Fuentes et al., 2000) . Although hypertension is the cause of mortality and morbidity in world (Rodger et al., 2004) but stroke in urban East-African countries is five times higher than in Britain (Walker et al., 2000) .
Nigella sativa is an annual herb belonging to family Ranunculaceae with huge medicinal potential. Its seeds and seeds extracts has been used medicinally for centuries especially in Mediterranean region, Middle-East and Southeast Asia (Rchid et al., 2004; Najmi, et al., 2008) . It has tremendous traditional and pharmacological potential in curing a wide range of ailments particularly hypotension (Aqel, 1992) (Tasawar et al., 2011) . N. sativa plant has strong antihypertensive effect that significantly lowered down blood pressure and cholesterol (Dehkordi and Kamkhah, 2008) . Reinhart et al. (2008) also reported its hypotensive, hypercholesterolemic, hypoglycaemic and antioxidative activities. N. sativa significantly reduces intracellular cholesterol by regulating LDL, HDL and triglycerides blood levels (El-Dakhakhany, 2000) . Obesity is the main cause of metabolic syndrome (Vega, 2001) . BMI is also an important indicator of metabolic syndrome (Najmi et al., 2008) . N. sativa showed a significant reduction in the body weight when administered to a experimental model of rats (Zaoui et al., 2002) . More than 100 bioactive compounds had been reported in the N. sativa seeds (Ramadan, 2007) . The therapeutic potential of medicinal plants is mainly due to the antioxidative properties of some active components (El-Saleh et al., 2004). The seeds of N. sativa contains two active components in its oils i.e. Thymoquinone and dihydrothymoquinone, revealed enormous potential of free radical scavenging capabilities (Khalife and Lupidi, 2007) . These biological active compounds considered largely as chemo protective (Badary et al., 1999 and Badary et al., 2007) , gastro protective (El-Abhar et al., 2003; Kanter et al., 2005) and immuno protective (Gilani et al., 2004) . The foods rich in fats after absorption through intestine intensify the hepatic detoxification, enhance lipid peroxidation and resulted debris cause cellular modifications. Cholesterol in the blood vessels also constructs fibrosis plaque along the walls. These plaques are atherosclerotic proliferation of the extra cellular matrix formed due to extensive biochemical and molecular changes within the vessels (Glass and Witztum, 2001; Tiwari et al., 2008) . Oxidation by free radicals is an imperative incident cause aging and human diseases.
The antioxidant screening of plants and their phytochemicals through comparing commercial antioxidants could help to find new source of expected innate antioxidants. N. sativa and its active components have tremendous potential of nutraceutical and pharmaceutical applications. This needs to be explored through more clinical studies in metabolic syndrome that is the challenge of future to medical professionals. The present study was undertaken to explore probable antioxidant potential of N. sativa found in its different parts which is responsible for lowering high blood pressure, serum cholesterol and plasma sugar. The data on the evaluation of N. sativa clinically and as antioxidant are scanty. This was the first ever study for validating the therapeutic potential of N. sativa in the state of Azad Kashmir, Pakistan.
Methodology and Materials

Patient Selecting Criterion
Patients with mild-moderate hypertension were selected from outpatient departments (OPD) of Abbass Institute of Medical Sciences (AIMS) Muzaffarabad and from medical camps organized through AIMS cardiology department. Before starting the study an approval from hospital ethical committee was taken. After explaining all the outcomes of the treatment and taken written consent from all participants (Supplementary Figure  3) , pathological history was recorded through questionnaire (Supplementary Figure 1) . During selection every aspect of patient interest focussed so that satisfies his convenience in perfection of better compliance. A total of 180 patients were registered for this clinical study which was divided in to two groups, each comprising 90 individuals. All patients were selected from the same geographical area randomly with a male and female ratio of 43 Patient's weight and height were measured for Body Mass Index calculation BMI (Kg/m²). Patient's systolic and diastolic blood pressure was recorded by using mercury Sphygmomanometer (Tycos Japan). Fasting blood samples (Venus) were taken in the hospital pathological laboratory and analysed for all biochemical tests using principal biochemistry analyzer and enzyme assays. Adverse events report proformas (Supplementary Figure 2) to report any adverse event and laboratory proformas (Supplementary Figure 4) to file all base line tests reports were prepared. A copy of each was given to patient for record. Patients were divided randomly including male and female's age ranged from 20-65 years into N. sativa and standard statin groups. One group was started with N. sativa oil treatment while second on statin standard treatment (atorvastatin 10 mg tablet once a day) and metformin 500 mg tablet one twice a day added to diabetics after taking a baseline data of all biochemical parameters. All the patients were strictly advised to follow the guide lines regarding physical activities, diet and maintained it regularly in routine life style. N. sativa seeds virgin oil (NsVO) administered orally twice a day in a dose of 0.5 ml before breakfast and going to bed for sleeping at night. During the study period patients were closely monitored through telephone calls, personal visits and every fortnight calls on hospital visits for blood http 
The Antioxidant Assay
Antioxidant potential of N. sativa and edible oils was evaluated by using free radical scavenging DPPH assay (2,2-diphenyl-1-picrylhydrazyl) as described by Amarowicz et al. (2004) . The absorbance was recorded at 517 nm through ultrospec-4000 (Pharmacia-LKB) UV-visible spectrophotometer. The radical scavenging activity was expressed as IC 50 . Ascorbic acid was used as standard. The percentage scavenging activity was calculated by using the following formula:
Percentage Inhibition = where A control is the absorbance of the control reaction, A extract is the absorbance of the test sample.
Results and Discussion
The study was undertaken with the aim to compare the antihypertensive and antihyperlipidemic effect of N. sativa virgin oil and standard statin treatments with their respective baseline data's in selected area. For this purpose 180 patients was screened out. Out of 180 patients 163 comply while 17 did not due to personal reasons. Statistical analysis showed that N. sativa has significant (P-value = < 0.05) effect on controlling hypertension (Systolic Bp P=3.079e-07; Diastolic Bp P=2.136e-06) and hyperlipidemia (Total cholesterol P = 2.2e-16, LDLc P = 2.2e-16, HDLc P = 4.739e-12 and TGs P = 0.05706) as compared to standard group (Systolic Bp P=5.505e-07; Diastolic Bp P = 1.005e-07; Total cholesterol P = 4.805e-13, LDLc P = 4.803e-10, HDLc P = 4.049e-06 and TGs P = 1.441e-07) through its antioxidative activities ( Fig. 1, 3) . Among the 83 patients 59 (71%) showed a significant decreased in blood pressure, 13 (16%) increased and 11 (13%) showed no effect of the treatment (Fig. 2) . In comparison to the 2nd group of standard treatment after 45 days the mean systolic (153.60 mmHg) and diastolic (95.18 mmHg) blood pressure at baselines was also reduced to 146.60 mmHg and 90.30 mmHg respectively ( Table 1, Fig. 4 ) but it was less than N. sativa group. Among the 80 patients receiving standard treatment 46 (57%) showed a decreased in blood pressure, 16 (20%) increased and 18 (23%) showed no effect of the treatment (Fig. 3) . The percent effect of N. sativa (71%) at individual levels was also better compared to standard group (57%). Various traditional and animal studies report the promising hypotensive action of the seeds and extracts of N. sativa. Rahman et al. (1990) ) found a reduction in the body mass index when used N. sativa seeds in a dose of 1.5 g/day for three months in obese individuals. Although their study conferred that the reduction in BMI and waist was not much significant but it had good impact on improving cholesterol. Moreover, In the N. sativa group the HDLc was raised 37.73-39.50 mg/dl while in standard group the value was 39.18-39.50 mg/dl which showed a significant (P = 4.739e-12) augment due to the N. sativa treatment. It has also been observed the high impact of the N. sativa treatment on the reduction of fasting blood glucose levels (~150-128 mg/dl) in comparison to the standard treatment (~147-144 mg/dl) at baseline ( Table 1 ; Fig. 4, 5) . Furthermore, when cholesterol and sugar levels were undertaken resulted lowered down along with blood pressure which also controlled due the fact that an increase in blood pressure found to be linked with increased cholesterol and sugar levels (SiokKoon et al., 2009). The systolic and diastolic blood pressure significantly lowered down with the increased in duration of the N. sativa treatment. The systolic blood pressure was decreased to ~134 mmHg after 90 days and ~127 mmHg after 180 days of N. sativa treatment at baseline of ~155 mmHg followed by decrease in diastolic blood pressure as ~83 mmHg and ~76 mmHg after 90 and 180 days at baseline of ~94 mmHg respectively (Table 2; Fig. 6 ). In case of standard treatment the systolic (~153 mmHg) blood pressure was decreased to ~145 and 138 mmHg after 90 and 180 days while the diastolic (~94 mmHg) was decreased to ~90 and ~84 mmHg after 90 and 180 days respectively ( Table 3 ; Fig. 7 ). Similarly patients receiving N. sativa showed a remarkable reduction in the mean total cholesterol, LDLc and triglycerides with the increase in HDLc after six month of treatment. The N. sativa group significantly reduced the cholesterol (199 and 186 mg/dl), LDLc (113 and 99 mg/dl), triglyceride (168 and 154 mg/dl) and fasting blood sugar (112 and 94 mg/dl) after 90 and 180 days of treatment at baselines of 220 mg/dl, 136 mg/dl, 191 mg/dl and 150 mg/dl respectively. The HDLc was increased to 40.80 mg/dl and 42.13 mg/dl at the baseline of 39.05 mg/dl after 90 and 180 days of N. sativa treatment respectively ( The systolic and diastolic Bp significantly (P-value = < 0.05) decreased when treatment of N. sativa was continued for another 45 days. The systolic and diastolic blood pressure was raised from ~143-148 mmHg and ~88-94 mmHg respectively when that group of patients was treated with placebo however, the total cholesterol was increased from ~200-209 mg/dl and LDLc ~102-125 mg/dl while no significant change was recorded in the levels of HDLc and triglycerides. Moreover a little change conferred in BMI (25.52-25.33 kg/m²) and waist circumference (91.32-90.12 cm) while blood sugar was raised from 128 -146 mg/dl ( Table 6 ). The antioxidant activity of the extracts of all lines of N. sativa was assessed by using DPPH assay and IC 50 value recorded was tabulated in Table 7 . Among seven lines tested, the N1 sample was found to be potent ( Table 7 ; Fig. 8 ). When compared different solvents extracts, the ethyl acetate was found to be a potent solvent for the extraction of potential compound with IC 50 values for N1 (0.0022), N2 (0.0033), N3 (0.0030) and N7 (0.4476) while methanol, chloroform and acetone extracts showed least activity ( Table 7 ; Fig. 8 ). Due to the factual antioxidant potential of seeds of N. sativa, a detail screening of all parts was carried out. Here also the N7 line was found to be potent. The IC 50 value recorded for ripen seeds was 0.000415 followed by unripe (green seeds) i.e. 3.510731 as compared to the standard used ( Table 8 ; Fig. 9a and 3c) . Other parts were found to be rubbished ( Table 8 ; Fig. 9b) . Vinha et al. (2005) reported that variation in antioxidant potential among all parts of same genotype was due to variation in secondary metabolites in different parts or may be due to extraction procedures, which is adopted for the extraction of active constituents. Commercially available edible oils were also screened with the purpose to compare their potential with selected genotype. It was found that N. sativa had great antioxidant potential as compared to the edible oils tested ( Table 9 ; Fig. 9d ). According to Skerget et al. (2005) sometime sampling of the same plant from the same ecological zone may deviate to the potential behavior because of mishandling of sampling procedures that could immediately oxidized the active metabolites and the antioxidant ability of the plants. http In the present findings of clinical studies the use of N. sativa virgin oil (N7) revealed a significant reduction in the blood pressure and other biochemical parameters. The evidence from literature also supports the findings that the antioxidants protect the body against the development of atherosclerosis and provide putative hypotensive effects (Rohdewald, 2002; Paulis and Simko, 2007) . Antioxidants contained melatonin (Flavonoids) can effectively be used in reducing blood pressure, lipid profile, body weight and plasma glucose (Hussein et al., 2007) . Antioxidants have strong impact of reducing the blood pressure which is also supported by a recent study (Rezzani et al., 2010 ) that described the protective role of antioxidants against the initiation of atherosclerosis in hypertensive animal model. Houghton et al. (1995) reported that the biologically active constituents of N. sativa had potent quenching capabilities for free radicals. On the basis of present findings it is conferred that the poor antioxidant effects in treating various pathological conditions are more or less due to improper dosage, methods of extraction, selection of the seeds cultivar and the selection of the seeds lots. So it is suggested that only an intellectual approach could succeed in achieving the desired results while implementing any treatment of plant material consisting these oxidants. Moreover the oxidative stress promptly impregnate its harmful effects on the arterial vasculature that require long time to correct in a smoothly manner. Allopathic drugs although provide to some instant relieve to the inflammation of the endothelial linings of the vasculature but could not be the sole solution to the whole imploratory process of atherosclerosis. 
Conclusion
On the basis of the current investigations it is concluded that N. sativa seeds and oil should be considered routinely in the management of diabetic and hypercholesterolemic disorders as remedy was found to be potent hypotensive, antihyperlipidemic and hypoglycaemic with strong antioxidative activities without any adverse effect. Nigella sativa proved to be the best alternatives remedial source to cure these fatal ailments with http://www. The beneficial effects of N. sativa in diabetic's subjects with fasting sugar, LDL, triglycerides, total cholesterol, BMI and high blood pressure were investigated and found highly significant (P = < 0.05) although the N. sativa was comparable to standards in short term but in longer therapy N. sativa revealed excellent role in controlling biochemical disorders. Maintaining serum glucose, serum cholesterol and high blood pressure at optimum reduces atherosclerosis and subsequently the risk of coronary heart diseases, a major threat to diabetic and hyperlipidemic patients. The potent antioxidative activities of N. sativa played a central role in functional optimization of biochemical parameters.
